See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Carbatrol, Equetro, Novo-Carbamazepine, Tegral, Tegretol, Tegretol CR, Tegretol XR
What is Carbamazepine?
Carbamazepine is an anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy and bipolar disorder. It is also used to treat schizophrenia and trigeminal neuralgia.
Read more...
See more information, including instructions, precautions, side effects, and interactions.
134 patients in the community are taking or have taken Carbamazepine.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Other | 29 | 21% |
| Treat my mood condition(s) | 24 | 17% |
| Pain | 22 | 16% |
| Stiffness/spasticity | 11 | 8% |
| trigeminal neuralgia | 7 | 5% |
| Don't know | 4 | 2% |
| Trigeminal neuralgia (tic douloureux) | 2 | 1% |
| Mood swings | 2 | 1% |
| Slow my MS progress | 2 | 1% |
| Neuropathy pain | 2 | 1% |
| disease-related symptoms | 2 | 1% |
| Headache | 1 | <1% |
| Shocklike spasms, tingling | 1 | <1% |
| Tonic spasms | 1 | <1% |
| Depression | 1 | <1% |
| Numbness, tingling, pins & needles (paresthesia) | 1 | <1% |
| Buzzing/vibration | 1 | <1% |
| Cramps | 1 | <1% |
| epilepsy | 1 | <1% |
| Balance problems | 1 | <1% |
| nerve pain | 1 | <1% |
| eye twitching | 1 | <1% |
| Partial seizures | 1 | <1% |
| twitches and jerks | 1 | <1% |
| Severe tingling numbness burning in my feet and hands | 1 | <1% |
| Persistent Migraine Aura without Infarction (Pain) | 1 | <1% |
| Slow my ALS progress | 1 | <1% |
How long current patients have been taking Carbamazepine or how long patients were taking Carbamazepine before stopping.
Results from 10 patient evaluations. See the overall results and all individual evaluations.
| Can't tell | 100% | 3 |
|---|
Treat my mood condition(s)
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 60% | 6 |
| Mild | 10% | 1 |
| None | 30% | 3 |
Top reported side-effects include: Mood swings, Increased Hunger, Dizziness
Summary results are based on 10 individual responses. For more information, see overall results for Adherence, Burden and Cost.